✦ LIBER ✦

Effects of the Cyclooxygenase Inhibiting Nitric Oxide Donator Naproxcinod Versus Naproxen on Systemic Blood Pressure in Patients With Osteoarthritis

✍ Scribed by William B. White; Thomas J. Schnitzer; Rosanna Fleming; Brigitte Duquesroix; Maarten Beekman

Book ID: 113445987
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 558 KB
Volume: 104
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2009.05.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS40 UTILITY AND QUALITY OF LIFE OF PAT

PMS40 UTILITY AND QUALITY OF LIFE OF PATIENTS WITH OSTEOARTHRITIS TREATED WITH THE CYCLOOXYGENASE INHIBITING NITRIC OXIDE DONATOR (CINOD) NAPROXCINOD

✍ B Jonsson; P Pfister; S Holmstrom; G Kobelt 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Blood pressure control and rates of edem

Blood pressure control and rates of edema following the administration of the cyclooxygenase-2 specific inhibitors celecoxib versus rofecoxib in patients with systemic hypertension and osteoarthritis

✍ Arthur Weaver; Michael Alderman; Rhoda Sperling 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Efficacy, safety, and effects on blood p

Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: A randomized, double-blind, parallel-group, multicenter study

✍ Christoph Baerwald; Paolo Verdecchia; Brigitte Duquesroix; Hayet Frayssinet; Thi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 3 views

The effects of cyclooxygenase-2 inhibito

The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus

✍ J.R. Sowers; W.B. White; B. Pitt 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 32 KB